# Colchicine in High-risk Patients With Acute Minor-to-moderate Ischemic Stroke or Transient Ischemic Attack (CHANCE-3)

> **NCT05439356** · PHASE3 · COMPLETED · sponsor: **Beijing Tiantan Hospital** · enrollment: 8343 (actual)

## Conditions studied

- Ischemic Stroke
- TIA

## Interventions

- **DRUG:** Colchicine
- **DRUG:** Placebo colchicine

## Key facts

- **NCT ID:** NCT05439356
- **Lead sponsor:** Beijing Tiantan Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-08-11
- **Primary completion:** 2023-07-13
- **Final completion:** 2024-04-12
- **Target enrollment:** 8343 (ACTUAL)
- **Last updated:** 2024-06-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05439356

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05439356, "Colchicine in High-risk Patients With Acute Minor-to-moderate Ischemic Stroke or Transient Ischemic Attack (CHANCE-3)". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05439356. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*